Trevor Collingwood

Chief Technology Officer at Acrigen Biosciences

Trevor is a leading expert in gene editing technology having worked with pioneers in the field link Sangamo and CRISPR Therapeutics. He is responsible for developing Acrigen’s Precision Gene Editing technology and applying it to therapeutic targets.


Org chart